Coagulopathy after snake envenomation in South Korea

Clin Toxicol (Phila). 2021 Oct;59(10):905-912. doi: 10.1080/15563650.2021.1884694. Epub 2021 Mar 1.

Abstract

Objective: This retrospective study investigated the nature and severity of venom-induced consumption coagulopathy (VICC) and determined the clotting factors involved in VICC in patients after envenomation by South Korea's snakes. Additionally, we studied the effectiveness of antivenom for the treatment of VICC after envenomation.

Methods: Included patients were divided into three groups according to the severity of VICC (no VICC, partial VICC, and complete VICC). Data, including changes in coagulation parameters during hospitalization and clotting factors at presentation, were collected and analyzed.

Results: One hundred nineteen patients who presented at our emergency department within 3 h after snake envenomation were included. VICC developed in 34 patients (27 patients with partial VICC and 7 patients with complete VICC). Two of 34 patients with VICC required blood transfusions. Five patients with complete VICC had an undetectable fibrinogen concentration at presentation. Three patients with complete VICC had an unmeasurable INR and aPTT within 24 h. The median times of the most extreme values were 10 h for INR, 12 h for aPTT, and 16 h for fibrinogen after presentation in the VICC group. The D-dimer concentration peaked at a median of 63.5 h after presentation. The activities of factors II and X were significantly reduced in the complete VICC group (factor II: 88 (84-99.3)% in the non-VICC group vs. 69 (49.5-83.5)% in the complete VICC group; factor X:94 (83-102) in the non-VICC group vs. 70 (66.5-79.8)% in the complete VICC group), while there was no difference in factor V activity at presentation. The time from bite to first antivenom administration did not correlate with the time course and most extreme concentrations for fibrinogen and D-dimer within the VICC groups.

Discussion and conclusion: VICC occurs in approximately one-quarter of snakebite patients in South Korea; however, VICC itself does not appear to lead to clinical deterioration. Fibrinogen is an early diagnostic maker for complete VICC. Clotting factors II and X are involved in VICC. Future investigations should explore the mechanism of VICC from Korean snakebites and the effect of antivenom on VICC.

Keywords: Crotalidae; Gloydius; coagulopathy; envenomation; retrospective study.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Animals
  • Antivenins / therapeutic use
  • Biomarkers / blood
  • Blood Coagulation Tests
  • Blood Coagulation* / drug effects
  • Disseminated Intravascular Coagulation / blood
  • Disseminated Intravascular Coagulation / diagnosis
  • Disseminated Intravascular Coagulation / drug therapy
  • Disseminated Intravascular Coagulation / etiology*
  • Factor X / metabolism
  • Female
  • Fibrinogen / metabolism
  • Humans
  • Male
  • Middle Aged
  • Prothrombin / metabolism
  • Republic of Korea
  • Retrospective Studies
  • Severity of Illness Index
  • Snake Bites / blood
  • Snake Bites / complications*
  • Snake Bites / diagnosis
  • Snake Bites / drug therapy
  • Snake Venoms / antagonists & inhibitors*
  • Snake Venoms / metabolism
  • Snakes*
  • Time Factors
  • Treatment Outcome

Substances

  • Antivenins
  • Biomarkers
  • Snake Venoms
  • Prothrombin
  • Factor X
  • Fibrinogen